GlucoTrack (NASDAQ:GCTK) Stock Rating Upgraded by Wall Street Zen

GlucoTrack (NASDAQ:GCTK) was upgraded by analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a report released on Saturday.

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GlucoTrack in a research note on Friday, July 17th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

GlucoTrack Price Performance

Shares of NASDAQ:GCTK opened at $0.43 on Friday. The company has a 50-day simple moving average of $0.43 and a 200-day simple moving average of $0.98. GlucoTrack has a one year low of $0.25 and a one year high of $14.14. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $3.34 million, a price-to-earnings ratio of -0.02 and a beta of 0.70.

Institutional Investors Weigh In On GlucoTrack

Hedge funds have recently added to or reduced their stakes in the company. Bank of America Corp DE raised its stake in shares of GlucoTrack by 102,125.0% during the 2nd quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after buying an additional 4,085 shares in the last quarter. Boothbay Fund Management LLC purchased a new stake in shares of GlucoTrack in the fourth quarter valued at approximately $52,000. Finally, Ikarian Capital LLC purchased a new stake in shares of GlucoTrack in the fourth quarter valued at approximately $177,000. Institutional investors and hedge funds own 10.92% of the company’s stock.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.